Addenbrookes NHS Trust Hospital

Cambridge, United Kingdom

Addenbrookes NHS Trust Hospital

Cambridge, United Kingdom

Time filter

Source Type

Langerak A.W.,Erasmus Medical Center | Groenen P.J.T.A.,Radboud University Nijmegen | Bruggemann M.,University of Kiel | Bellan C.,University of Siena | And 22 more authors.
Leukemia | Year: 2012

PCR-based immunoglobulin (Ig)/T-cell receptor (TCR) clonality testing in suspected lymphoproliferations has largely been standardized and has consequently become technically feasible in a routine diagnostic setting. Standardization of the pre-analytical and post-analytical phases is now essential to prevent misinterpretation and incorrect conclusions derived from clonality data. As clonality testing is not a quantitative assay, but rather concerns recognition of molecular patterns, guidelines for reliable interpretation and reporting are mandatory. Here, the EuroClonality (BIOMED-2) consortium summarizes important pre- and post-analytical aspects of clonality testing, provides guidelines for interpretation of clonality testing results, and presents a uniform way to report the results of the Ig/TCR assays. Starting from an immunobiological concept, two levels to report Ig/TCR profiles are discerned: the technical description of individual (multiplex) PCR reactions and the overall molecular conclusion for B and T cells. Collectively, the EuroClonality (BIOMED-2) guidelines and consensus reporting system should help to improve the general performance level of clonality assessment and interpretation, which will directly impact on routine clinical management (standardized best-practice) in patients with suspected lymphoproliferations. © 2012 Macmillan Publishers Limited.

Loading Addenbrookes NHS Trust Hospital collaborators
Loading Addenbrookes NHS Trust Hospital collaborators